Warren T. Phipps

Warren T. Phipps, MD, MPH is an Associate Professor at Fred Hutchinson Cancer Center (Vaccine and Infectious Disease Division) and the University of Washington School of Medicine (Department of Medicine, Division of Allergy and Infectious Diseases). He serves as Deputy Director of the Global Oncology Program, Medical Director of the UCI-Fred Hutch Collaboration, and Member of the Immunotherapy Integrated Research Center. Based primarily in Kampala, Uganda, he leads clinical and research efforts at the UCI-Fred Hutch Cancer Centre focusing on HIV-associated malignancies.

Dr. Phipps earned his BA from Yale University (1993), MD from Harvard Medical School (2002), and MPH from the University of Washington School of Public Health (2009). His educational background bridges clinical medicine, public health, and infectious disease specialization.

His research centers on Kaposi sarcoma (KS) pathogenesis in HIV-positive and HIV-negative populations, leveraging one of the world's largest KS patient cohorts with over 1,000 tumor biopsies collected in Uganda. Key investigations include T-cell immune responses to KS, genomic analysis of cellular mutations and clonality, HHV-8 transcriptomics, and causes of neutropenic fever in immunocompromised cancer patients. His work integrates virology, oncology, and immunology to address cancer disparities in resource-limited settings.

No scientific awards were specified in the source material.

Dr. Phipps mentors trainees in global oncology and infectious disease research through the UCI-Fred Hutch Cancer Centre partnership. He co-chairs the Uganda Cancer Institute's COVID-19 Task Force and collaborates with Uganda's Ministry of Health on pandemic response initiatives, including establishing national testing infrastructure. His decade-long leadership in the UCI-Fred Hutch Collaboration demonstrates sustained commitment to capacity building.

He directs a multidisciplinary research team in Kampala conducting translational studies on KS virology and immune responses. The team operates within the UCI-Fred Hutch Cancer Centre, which celebrated its 10th anniversary in 2018, focusing on integrating clinical care, biospecimen collection, and therapeutic innovation for HIV-associated cancers in sub-Saharan Africa.